Article metrics

Download PDFPDF

A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2024

AbstractFullPdf
Dec 2019021
Jan 2020021
Feb 2020021
Mar 2020031
Apr 2020042
Jun 20200150
Jul 2020070
Sep 2020070
Oct 2020020
Nov 2020040
Dec 2020020
Jan 2021050
Feb 2021033
Mar 2021040
Apr 2021041
May 2021041
Jun 2021030
Jul 2021042
Aug 2021010
Sep 2021020
Oct 2021052
Nov 2021061
Dec 2021050
Jan 2022040
Feb 2022030
Mar 2022050
Apr 2022040
May 2022053
Jun 2022051
Jul 2022070
Aug 2022061
Sep 2022061
Oct 2022030
Nov 2022040
Dec 20220102
Jan 2023091
Feb 2023070
Mar 2023030
Apr 2023023
May 2023040
Jun 2023011
Jul 2023022
Aug 2023011
Sep 2023034
Oct 2023082
Nov 2023081
Dec 20230110
Jan 2024030
Feb 20240113
Mar 20240762
Apr 20240810
May 2024074
Total0253118